CLONIDINE

CLONIDINE was reported 51846 times

CLONIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WITHDRAWAL HYPERTENSION 53 0.2624
1 DEVICE WIRELESS COMMUNICATION ISSUE 67 0.2587
2 NEOVASCULARISATION 60 0.2281
3 VICTIM OF CHILD ABUSE 49 0.1952
4 TEMPERATURE REGULATION DISORDER 430 0.1928
5 DEVICE MAINTENANCE ISSUE 100 0.1701
6 CHILD ABUSE 42 0.1622
7 EPIDURAL LIPOMATOSIS 54 0.1570
8 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147 0.1384
9 NEPHROGENIC ANAEMIA 564 0.1216
10 HYPERPARATHYROIDISM SECONDARY 296 0.1180
11 OPPOSITIONAL DEFIANT DISORDER 43 0.1089
12 BODY TINEA 55 0.0982
13 INFUSION SITE DISCHARGE 153 0.0872
14 INFUSION SITE IRRITATION 107 0.0833
15 INFUSION SITE INDURATION 117 0.0789
16 INFUSION SITE NODULE 72 0.0749
17 DEVICE INFUSION ISSUE 184 0.0741
18 INFUSION SITE HAEMORRHAGE 240 0.0729
19 INFUSION SITE WARMTH 87 0.0710
20 FOOD ALLERGY 548 0.0709
21 INFUSION SITE INFECTION 161 0.0692
22 INFUSION SITE INFLAMMATION 48 0.0680
23 INFUSION SITE DISCOLOURATION 58 0.0659
24 INFUSION SITE PAIN 840 0.0651
25 IMPLANT SITE EXTRAVASATION 49 0.0623
26 INFUSION SITE ERYTHEMA 524 0.0621
27 END STAGE RENAL DISEASE 1124 0.0616
28 INFUSION SITE MASS 66 0.0607
29 INFUSION SITE SWELLING 374 0.0594
30 REBOUND ACID HYPERSECRETION 174 0.0575
31 CHOREOATHETOSIS 39 0.0574
32 FOETAL DEATH 259 0.0499
33 MALIGNANT HYPERTENSION 40 0.0466
34 NEPHROGENIC SYSTEMIC FIBROSIS 135 0.0446
35 INFUSION SITE REACTION 130 0.0435
36 INFUSION SITE DISCOMFORT 45 0.0434
37 HYPERTENSIVE EMERGENCY 50 0.0424
38 COELIAC DISEASE 408 0.0416
39 INFUSION SITE PRURITUS 123 0.0389
40 IMMUNODEFICIENCY 573 0.0384
41 SUSPECTED SUICIDE 178 0.0379
42 INHIBITORY DRUG INTERACTION 59 0.0372
43 BURSITIS 427 0.0352
44 DEVICE ALARM ISSUE 63 0.0347
45 INFUSION SITE RASH 45 0.0328
46 SKIN INDURATION 64 0.0308
47 BLOOD PRESSURE INADEQUATELY CONTROLLED 185 0.0307
48 DEVICE POWER SOURCE ISSUE 88 0.0301
49 PARADOXICAL DRUG REACTION 109 0.0296
50 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73 0.0295
51 CHRONIC KIDNEY DISEASE 2117 0.0278
52 INFECTION SUSCEPTIBILITY INCREASED 59 0.0269
53 LEFT VENTRICULAR HYPERTROPHY 113 0.0264
54 INFUSION SITE BRUISING 56 0.0259
55 PRESCRIBED OVERDOSE 497 0.0257
56 DEVICE CONNECTION ISSUE 49 0.0232
57 JUVENILE IDIOPATHIC ARTHRITIS 56 0.0229
58 HYPERTENSIVE CRISIS 253 0.0227
59 SKIN HYPERTROPHY 63 0.0224
60 RESPIRATORY DEPRESSION 273 0.0223
61 KIDNEY FIBROSIS 38 0.0219
62 RENAL INJURY 643 0.0216
63 DISTRIBUTIVE SHOCK 49 0.0216
64 SINUS BRADYCARDIA 205 0.0212
65 HOMICIDAL IDEATION 83 0.0205
66 HYPERTENSIVE HEART DISEASE 38 0.0203
67 KIDNEY TRANSPLANT REJECTION 95 0.0198
68 PURULENT DISCHARGE 84 0.0196
69 RENAL FAILURE CHRONIC 144 0.0187
70 APPLICATION SITE PRURITUS 416 0.0183
71 OBESITY 291 0.0182
72 APLASTIC ANAEMIA 95 0.0182
73 IMPLANT SITE INFECTION 41 0.0176
74 PRODUCT ADHESION ISSUE 628 0.0176
75 TIC 93 0.0170
76 FIBROSIS 52 0.0169
77 NEPHROPATHY 155 0.0166
78 SEDATION COMPLICATION 42 0.0164
79 NEUROLOGICAL DECOMPENSATION 38 0.0164
80 HYPOVENTILATION 53 0.0162
81 RENAL TUBULAR NECROSIS 157 0.0160
82 COMPLETED SUICIDE 1333 0.0160
83 APPLICATION SITE BURN 76 0.0154
84 APPLICATION SITE RASH 210 0.0153
85 MENTAL STATUS CHANGES 423 0.0152
86 GLUCOSE TOLERANCE IMPAIRED 88 0.0149
87 HYPERLIPIDAEMIA 176 0.0147
88 APPLICATION SITE ERYTHEMA 386 0.0147
89 BLOOD PRESSURE DIASTOLIC ABNORMAL 37 0.0145
90 FLUID RETENTION 738 0.0145
91 UPPER RESPIRATORY TRACT INFECTION 669 0.0145
92 RENAL FAILURE 1922 0.0145
93 CATATONIA 76 0.0145
94 BLOOD PROLACTIN INCREASED 68 0.0144
95 AUTONOMIC NERVOUS SYSTEM IMBALANCE 42 0.0144
96 PSYCHOMOTOR HYPERACTIVITY 237 0.0143
97 HYPERREFLEXIA 49 0.0141
98 SEDATION 368 0.0140
99 HYPERAESTHESIA 115 0.0140
100 DERMATITIS CONTACT 159 0.0139
101 BRADYCARDIA 736 0.0139
102 ATRIOVENTRICULAR BLOCK FIRST DEGREE 60 0.0138
103 DIABETIC NEUROPATHY 68 0.0137
104 RENAL TRANSPLANT 49 0.0136
105 MULTIPLE DRUG OVERDOSE 67 0.0135
106 MIOSIS 105 0.0131
107 DEVICE FAILURE 198 0.0130
108 IMPLANT SITE PAIN 58 0.0130
109 APPLICATION SITE VESICLES 84 0.0129
110 HYPERTENSION 2740 0.0129
111 ECONOMIC PROBLEM 193 0.0127
112 DIABETIC RETINOPATHY 43 0.0126
113 OVERWEIGHT 68 0.0126
114 IMPULSIVE BEHAVIOUR 47 0.0125
115 CONTRAINDICATED PRODUCT ADMINISTERED 374 0.0123
116 HYPERVOLAEMIA 61 0.0123
117 TUBULOINTERSTITIAL NEPHRITIS 231 0.0123
118 ACUTE KIDNEY INJURY 1861 0.0121
119 DRUG TOLERANCE 61 0.0120
120 RASH ERYTHEMATOUS 575 0.0120
121 INTERVERTEBRAL DISC DISORDER 51 0.0119
122 ANURIA 102 0.0118
123 DEVICE KINK 43 0.0118
124 BUNDLE BRANCH BLOCK LEFT 50 0.0118
125 SKIN TIGHTNESS 55 0.0117
126 PULSELESS ELECTRICAL ACTIVITY 48 0.0115
127 KLEBSIELLA INFECTION 58 0.0115
128 BLOOD PRESSURE INCREASED 1753 0.0115
129 DEVICE OCCLUSION 160 0.0114
130 POISONING 142 0.0113
131 APPLICATION SITE IRRITATION 140 0.0112
132 SPRUE-LIKE ENTEROPATHY 55 0.0111
133 OESOPHAGEAL PAIN 44 0.0111
134 NEUROLEPTIC MALIGNANT SYNDROME 132 0.0111
135 AGGRESSION 557 0.0111
136 TRISMUS 56 0.0108
137 BRUXISM 58 0.0107
138 HAEMOGLOBIN INCREASED 49 0.0107
139 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 55 0.0107
140 RENAL CYST 84 0.0106
141 BLOOD PRESSURE FLUCTUATION 253 0.0105
142 APNOEA 82 0.0105
143 ALCOHOLISM 45 0.0105
144 ANHEDONIA 276 0.0105
145 CARDIOMEGALY 129 0.0105
146 HYPERCHOLESTEROLAEMIA 101 0.0105
147 HEPATIC ENZYME INCREASED 713 0.0104
148 PROCTALGIA 66 0.0103
149 DRUG SCREEN POSITIVE 81 0.0102
150 SLEEP APNOEA SYNDROME 195 0.0102
151 WITHDRAWAL SYNDROME 428 0.0102
152 ABDOMINAL TENDERNESS 50 0.0101
153 ARTERIOSCLEROSIS 94 0.0100
154 HYPERHIDROSIS 1281 0.0099
155 MONOPLEGIA 43 0.0099
156 POOR QUALITY SLEEP 213 0.0099
157 APPLICATION SITE DISCOLOURATION 40 0.0098
158 TOXIC EPIDERMAL NECROLYSIS 149 0.0098
159 TENDERNESS 102 0.0098
160 RESPIRATORY ACIDOSIS 38 0.0097
161 CARDIAC FAILURE CONGESTIVE 773 0.0096
162 BEHAVIOUR DISORDER 52 0.0096
163 SUPRAVENTRICULAR TACHYCARDIA 92 0.0096
164 HYPOVOLAEMIA 56 0.0096
165 POST-TRAUMATIC STRESS DISORDER 64 0.0095
166 JOINT RANGE OF MOTION DECREASED 128 0.0095
167 IMPAIRED GASTRIC EMPTYING 130 0.0095
168 HYPOTONIA 94 0.0094
169 UNRESPONSIVE TO STIMULI 243 0.0094
170 ESCHERICHIA URINARY TRACT INFECTION 40 0.0094
171 DROOLING 65 0.0094
172 HAEMORRHAGIC ANAEMIA 41 0.0093
173 IMPAIRED QUALITY OF LIFE 134 0.0093
174 CORONARY ARTERY DISEASE 281 0.0093
175 RESPIRATORY ARREST 255 0.0092
176 CARDIO-RESPIRATORY ARREST 384 0.0092
177 HYPERVENTILATION 53 0.0091
178 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 62 0.0091
179 NEUROLOGICAL SYMPTOM 52 0.0091
180 HYPOTHERMIA 92 0.0091
181 PERIPHERAL VASCULAR DISORDER 46 0.0089
182 DYSTONIA 173 0.0089
183 BRAIN INJURY 89 0.0089
184 EXPOSURE DURING PREGNANCY 551 0.0089
185 VASCULAR DEVICE INFECTION 40 0.0088
186 JOINT DISLOCATION 93 0.0088
187 NO THERAPEUTIC RESPONSE 107 0.0088
188 BLOOD PRESSURE ABNORMAL 174 0.0087
189 SPINAL OSTEOARTHRITIS 76 0.0086
190 RALES 50 0.0086
191 AFFECTIVE DISORDER 67 0.0085
192 DRUG WITHDRAWAL SYNDROME 745 0.0085
193 SCREAMING 54 0.0085
194 TYPE 2 DIABETES MELLITUS 285 0.0085
195 MUSCLE SPASTICITY 104 0.0085
196 DIVERTICULUM 60 0.0084
197 BLOOD PRESSURE SYSTOLIC INCREASED 164 0.0084
198 LYMPHOEDEMA 58 0.0084
199 INFUSION RELATED REACTION 554 0.0083
200 PERITONITIS BACTERIAL 84 0.0083
201 RETCHING 177 0.0083
202 TYPE 1 DIABETES MELLITUS 50 0.0083
203 IMMUNE THROMBOCYTOPENIA 38 0.0083
204 PULMONARY CONGESTION 109 0.0083
205 BLOOD PRESSURE DIASTOLIC INCREASED 38 0.0082
206 INTERVERTEBRAL DISC DEGENERATION 76 0.0082
207 RENAL FAILURE ACUTE 347 0.0082
208 FLUID OVERLOAD 119 0.0082
209 ATELECTASIS 79 0.0082
210 SKIN ATROPHY 47 0.0082
211 ARTERIOSCLEROSIS CORONARY ARTERY 54 0.0081
212 PURPURA 72 0.0081
213 SEROTONIN SYNDROME 156 0.0081
214 HYPERKALAEMIA 283 0.0081
215 TRICUSPID VALVE INCOMPETENCE 64 0.0080
216 APPLICATION SITE SWELLING 40 0.0080
217 URINE OUTPUT DECREASED 70 0.0080
218 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 76 0.0080
219 HYPOTENSION 1595 0.0079
220 AGITATION 581 0.0079
221 SCOLIOSIS 49 0.0079
222 LETHARGY 455 0.0079
223 ENTEROCOCCAL INFECTION 38 0.0079
224 FEELING OF BODY TEMPERATURE CHANGE 46 0.0078
225 DISSOCIATION 60 0.0078
226 ELECTROCARDIOGRAM ABNORMAL 61 0.0078
227 PRODUCT ADMINISTRATION INTERRUPTED 61 0.0078
228 BLOOD POTASSIUM INCREASED 126 0.0078
229 HEART RATE DECREASED 272 0.0077
230 HAEMODIALYSIS 65 0.0077
231 STREPTOCOCCAL INFECTION 43 0.0077
232 MYOCLONUS 92 0.0077
233 INTENTIONAL PRODUCT MISUSE 675 0.0077
234 MULTIPLE INJURIES 48 0.0076
235 AKATHISIA 104 0.0076
236 ABNORMAL BEHAVIOUR 301 0.0076
237 ACIDOSIS 58 0.0076
238 DECREASED IMMUNE RESPONSIVENESS 74 0.0075
239 CARDIAC MURMUR 65 0.0075
240 DIALYSIS 106 0.0075
241 ACUTE MYOCARDIAL INFARCTION 220 0.0075
242 HYPERNATRAEMIA 37 0.0074
243 CARDIAC ARREST 612 0.0074
244 BLOOD UREA INCREASED 124 0.0074
245 FAILURE TO THRIVE 38 0.0073
246 ASPIRATION 80 0.0073
247 DYSLIPIDAEMIA 37 0.0073
248 APPLICATION SITE PAIN 160 0.0073
249 LUNG INFILTRATION 64 0.0072
250 DELIRIUM 251 0.0072
251 OBSESSIVE-COMPULSIVE DISORDER 58 0.0072
252 BIPOLAR DISORDER 78 0.0072
253 CARDIOMYOPATHY 106 0.0072
254 FIBROMYALGIA 174 0.0072
255 THERAPY NON-RESPONDER 321 0.0071
256 DYSKINESIA 290 0.0071
257 HIATUS HERNIA 92 0.0071
258 ACUTE RESPIRATORY FAILURE 136 0.0071
259 BLOOD MAGNESIUM DECREASED 61 0.0071
260 STRESS CARDIOMYOPATHY 41 0.0070
261 GOUT 126 0.0070
262 INADEQUATE ANALGESIA 59 0.0069
263 TOXICITY TO VARIOUS AGENTS 1170 0.0069
264 FAECALOMA 38 0.0069
265 INGUINAL HERNIA 42 0.0069
266 DECREASED ACTIVITY 74 0.0069
267 ASTHMA 775 0.0068
268 HYPOPHAGIA 175 0.0068
269 DRUG ABUSER 42 0.0068
270 BLOOD SODIUM DECREASED 128 0.0068
271 PRODUCT LEAKAGE 38 0.0068
272 MEDICAL DEVICE COMPLICATION 50 0.0068
273 REFUSAL OF TREATMENT BY PATIENT 44 0.0067
274 PULMONARY HYPERTENSION 140 0.0067
275 DRUG TOXICITY 91 0.0067
276 HYPOXIA 235 0.0067
277 DEVICE PHYSICAL PROPERTY ISSUE 51 0.0067
278 AFFECT LABILITY 64 0.0066
279 LOWER GASTROINTESTINAL HAEMORRHAGE 49 0.0066
280 BLOOD TRIGLYCERIDES INCREASED 117 0.0066
281 BLOOD CREATININE INCREASED 432 0.0066
282 EXTRAPYRAMIDAL DISORDER 164 0.0066
283 MULTI-ORGAN FAILURE 114 0.0066
284 MYOCARDIAL ISCHAEMIA 75 0.0066
285 URINARY INCONTINENCE 195 0.0066
286 PULMONARY OEDEMA 292 0.0065
287 OEDEMA PERIPHERAL 794 0.0065
288 FEAR 175 0.0065
289 DIZZINESS POSTURAL 63 0.0065
290 INCOHERENT 42 0.0065
291 HALLUCINATION, AUDITORY 103 0.0065
292 POLYURIA 53 0.0065
293 ANGINA UNSTABLE 42 0.0065
294 TRANSIENT ISCHAEMIC ATTACK 218 0.0065
295 MITRAL VALVE INCOMPETENCE 73 0.0064
296 MALNUTRITION 72 0.0064
297 PRODUCT PRESCRIBING ERROR 153 0.0064
298 DEPRESSED LEVEL OF CONSCIOUSNESS 254 0.0064
299 HYPERTHERMIA 49 0.0064
300 BLOOD PRESSURE DECREASED 426 0.0064
301 SOMNAMBULISM 42 0.0064
302 SUBSTANCE ABUSE 52 0.0064
303 RESPIRATORY DISTRESS 176 0.0064
304 BLOOD PRESSURE DIASTOLIC DECREASED 47 0.0064
305 ELECTROCARDIOGRAM QT PROLONGED 229 0.0064
306 HYPERSOMNIA 182 0.0063
307 CONSTIPATION 1384 0.0063
308 RESTLESSNESS 232 0.0063
309 MANIA 104 0.0063
310 ECCHYMOSIS 43 0.0063
311 PSYCHOLOGICAL TRAUMA 54 0.0063
312 GASTROOESOPHAGEAL REFLUX DISEASE 501 0.0062
313 ANGER 210 0.0062
314 ATRIOVENTRICULAR BLOCK 48 0.0062
315 RENAL DISORDER 289 0.0062
316 CELLULITIS 312 0.0062
317 DRY MOUTH 502 0.0062
318 COAGULOPATHY 103 0.0062
319 RESPIRATORY FAILURE 450 0.0062
320 BACK PAIN 1432 0.0062
321 MAJOR DEPRESSION 45 0.0062
322 HAEMORRHOIDS 120 0.0061
323 DENTAL CARIES 68 0.0061
324 CHOLECYSTITIS 73 0.0061
325 ELECTROLYTE IMBALANCE 71 0.0061
326 GENERALISED TONIC-CLONIC SEIZURE 101 0.0061
327 PRE-EXISTING CONDITION IMPROVED 38 0.0061
328 LEUKOCYTOSIS 110 0.0061
329 HYPOKALAEMIA 280 0.0061
330 ACUTE CORONARY SYNDROME 50 0.0060
331 ATRIAL FLUTTER 48 0.0060
332 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 330 0.0060
333 SEASONAL ALLERGY 85 0.0060
334 RHEUMATOID ARTHRITIS 681 0.0060
335 CARDIOGENIC SHOCK 86 0.0060
336 OEDEMA 324 0.0060
337 JOINT SWELLING 721 0.0060
338 INCONTINENCE 63 0.0060
339 ILEUS 74 0.0059
340 MYDRIASIS 76 0.0059
341 SOMNOLENCE 1184 0.0059
342 SEIZURE 679 0.0059
343 GASTROENTERITIS VIRAL 106 0.0059
344 TRANSPLANT REJECTION 47 0.0059
345 HAEMATOCRIT DECREASED 116 0.0058
346 TARDIVE DYSKINESIA 165 0.0058
347 TACHYCARDIA 519 0.0058
348 APPLICATION SITE REACTION 41 0.0058
349 HAIR DISORDER 48 0.0058
350 IRRITABILITY 350 0.0058
351 DRUG INTERACTION 923 0.0058
352 DIABETES MELLITUS INADEQUATE CONTROL 103 0.0058
353 ANXIETY 1655 0.0058
354 PARANOIA 100 0.0058
355 INJURY 407 0.0058
356 COLITIS ISCHAEMIC 39 0.0058
357 RHABDOMYOLYSIS 241 0.0058
358 DECUBITUS ULCER 47 0.0058
359 CRYING 209 0.0057
360 AUTOIMMUNE DISORDER 56 0.0057
361 HYDRONEPHROSIS 43 0.0057
362 TORSADE DE POINTES 45 0.0057
363 EXTRASYSTOLES 40 0.0057
364 SPINAL PAIN 67 0.0057
365 GASTRITIS 150 0.0057
366 OXYGEN SATURATION DECREASED 320 0.0057
367 HEPATIC STEATOSIS 106 0.0057
368 PROTEINURIA 108 0.0057
369 COORDINATION ABNORMAL 79 0.0057
370 WOUND INFECTION 62 0.0057
371 IMPAIRED WORK ABILITY 121 0.0057
372 HAEMODYNAMIC INSTABILITY 43 0.0056
373 RESPIRATORY RATE INCREASED 50 0.0056
374 GLOMERULAR FILTRATION RATE DECREASED 69 0.0056
375 PRODUCT USE ISSUE 1053 0.0056
376 BLOOD POTASSIUM DECREASED 168 0.0056
377 HYPERGLYCAEMIA 203 0.0056
378 ANAL INCONTINENCE 50 0.0056
379 TREATMENT NONCOMPLIANCE 304 0.0056
380 BLOOD ALBUMIN DECREASED 44 0.0055
381 HYPOGLYCAEMIA 269 0.0055
382 SCIATICA 88 0.0055
383 MIDDLE INSOMNIA 103 0.0055
384 RED BLOOD CELL SEDIMENTATION RATE INCREASED 61 0.0055
385 PRESYNCOPE 134 0.0055
386 PAIN IN JAW 156 0.0055
387 TREATMENT FAILURE 456 0.0055
388 OVERDOSE 1181 0.0055
389 HYPERSENSITIVITY 1012 0.0054
390 JOINT STIFFNESS 143 0.0054
391 FLANK PAIN 51 0.0054
392 ACCIDENTAL OVERDOSE 199 0.0054
393 DRUG LEVEL INCREASED 90 0.0054
394 GENERALISED OEDEMA 67 0.0054
395 OSTEOMYELITIS 98 0.0054
396 HEART RATE INCREASED 536 0.0054
397 HYPOALBUMINAEMIA 42 0.0054
398 STAPHYLOCOCCAL INFECTION 178 0.0054
399 DRUG INTOLERANCE 521 0.0054
400 DEVICE RELATED INFECTION 83 0.0054
401 HAEMATURIA 184 0.0054
402 PERICARDIAL EFFUSION 124 0.0054
403 HALLUCINATION 404 0.0054
404 CONVULSION 306 0.0053
405 ORTHOSTATIC HYPOTENSION 93 0.0053
406 VITAMIN D DEFICIENCY 52 0.0053
407 CORONARY ARTERY OCCLUSION 73 0.0053
408 THERAPY PARTIAL RESPONDER 83 0.0053
409 CHEST PAIN 985 0.0053
410 IRON DEFICIENCY ANAEMIA 49 0.0053
411 OSTEOARTHRITIS 225 0.0053
412 GRAND MAL CONVULSION 49 0.0053
413 PAROSMIA 40 0.0053
414 INTENTIONAL OVERDOSE 340 0.0053
415 SINUS TACHYCARDIA 75 0.0053
416 CYSTITIS 168 0.0053
417 OSTEOPENIA 80 0.0053
418 HAEMORRHAGIC STROKE 41 0.0052
419 DISTURBANCE IN ATTENTION 283 0.0052
420 BODY HEIGHT DECREASED 56 0.0052
421 HYPOKINESIA 76 0.0052
422 SPEECH DISORDER 274 0.0052
423 RESTLESS LEGS SYNDROME 95 0.0052
424 COLD SWEAT 92 0.0052
425 SENSORY LOSS 42 0.0052
426 RENAL IMPAIRMENT 438 0.0052
427 HALLUCINATION, VISUAL 110 0.0052
428 DYSARTHRIA 196 0.0052
429 SCAR 89 0.0052
430 SALIVARY HYPERSECRETION 52 0.0052
431 KIDNEY INFECTION 102 0.0052
432 TREMOR 860 0.0052
433 HAIR COLOUR CHANGES 64 0.0051
434 IRRITABLE BOWEL SYNDROME 110 0.0051
435 STEVENS-JOHNSON SYNDROME 114 0.0051
436 PAIN 3149 0.0051
437 EMOTIONAL DISORDER 158 0.0051
438 SPLENOMEGALY 60 0.0051
439 DIABETES MELLITUS 390 0.0051
440 MOOD SWINGS 163 0.0051
441 GYNAECOMASTIA 158 0.0051
442 IMPAIRED DRIVING ABILITY 58 0.0051
443 BODY TEMPERATURE INCREASED 104 0.0051
444 INITIAL INSOMNIA 52 0.0051
445 LOSS OF CONSCIOUSNESS 649 0.0051
446 MUSCLE TIGHTNESS 82 0.0051
447 GASTROINTESTINAL HAEMORRHAGE 422 0.0050
448 INSOMNIA 1344 0.0050
449 BACK DISORDER 82 0.0050
450 CANDIDA INFECTION 85 0.0050
451 VITAMIN D DECREASED 43 0.0050
452 DISORIENTATION 199 0.0050
453 HAEMORRHAGE INTRACRANIAL 75 0.0050
454 WRONG TECHNIQUE IN DRUG USAGE PROCESS 182 0.0050
455 DEVICE INFORMATION OUTPUT ISSUE 39 0.0050
456 TOOTH ABSCESS 51 0.0050
457 THROMBOCYTOPENIA 560 0.0050
458 VENTRICULAR EXTRASYSTOLES 52 0.0050
459 PRODUCT SUBSTITUTION ISSUE 288 0.0050
460 DEHYDRATION 665 0.0050
461 SUICIDAL IDEATION 456 0.0050
462 TRANSFUSION 52 0.0050
463 MUSCLE TWITCHING 114 0.0049
464 OBSTRUCTIVE AIRWAYS DISORDER 55 0.0049
465 INCREASED APPETITE 94 0.0049
466 QUALITY OF LIFE DECREASED 66 0.0049
467 CEREBROVASCULAR ACCIDENT 833 0.0049
468 SKIN DISORDER 164 0.0049
469 DYSPNOEA EXERTIONAL 185 0.0049
470 HYPOAESTHESIA 735 0.0049
471 NECK PAIN 274 0.0049
472 BLOOD CHOLESTEROL INCREASED 228 0.0049
473 INCREASED TENDENCY TO BRUISE 45 0.0049
474 BODY TEMPERATURE DECREASED 48 0.0049
475 MUSCULAR WEAKNESS 553 0.0049
476 AORTIC ANEURYSM 37 0.0049
477 VENTRICULAR FIBRILLATION 54 0.0049
478 ENCEPHALOPATHY 119 0.0048
479 WEIGHT INCREASED 1085 0.0048
480 DYSURIA 178 0.0048
481 NODULE 63 0.0048
482 SYNCOPE 483 0.0048
483 GALLBLADDER DISORDER 86 0.0048
484 METABOLIC ACIDOSIS 154 0.0048
485 SUBARACHNOID HAEMORRHAGE 49 0.0048
486 PHARYNGEAL OEDEMA 74 0.0048
487 PANIC ATTACK 175 0.0048
488 LACERATION 45 0.0048
489 DEVICE DISLOCATION 208 0.0048
490 ANKLE FRACTURE 74 0.0048
491 ORAL PAIN 107 0.0048
492 CONTUSION 460 0.0048
493 NEURALGIA 116 0.0048
494 HELICOBACTER INFECTION 49 0.0048
495 PULMONARY MASS 71 0.0048
496 PANCREATITIS ACUTE 107 0.0048
497 URINARY TRACT INFECTION 811 0.0047
498 SPINAL DISORDER 45 0.0047
499 HEADACHE 2979 0.0047
500 EYE HAEMORRHAGE 63 0.0047
501 BACTERAEMIA 56 0.0047
502 MUSCULOSKELETAL CHEST PAIN 73 0.0047
503 ROAD TRAFFIC ACCIDENT 197 0.0047
504 TACHYPNOEA 64 0.0047
505 HYPONATRAEMIA 264 0.0047
506 WEIGHT DECREASED 1307 0.0047
507 EAR PAIN 91 0.0047
508 HYPOTHYROIDISM 149 0.0047
509 SLEEP DISORDER 329 0.0047
510 MOOD ALTERED 127 0.0047
511 NERVOUSNESS 243 0.0046
512 DRUG ABUSE 387 0.0046
513 ACTIVITIES OF DAILY LIVING IMPAIRED 92 0.0046
514 DEPRESSION 1057 0.0046
515 DRUG USE DISORDER 39 0.0046
516 HAIR TEXTURE ABNORMAL 62 0.0046
517 ORAL CANDIDIASIS 61 0.0046
518 IMPAIRED HEALING 152 0.0046
519 TOOTH FRACTURE 51 0.0046
520 HEMIPARESIS 78 0.0046
521 PNEUMONIA ASPIRATION 115 0.0046
522 HEART RATE IRREGULAR 104 0.0046
523 DEFORMITY 43 0.0046
524 VIRAL INFECTION 153 0.0046
525 BACK INJURY 50 0.0046
526 ROTATOR CUFF SYNDROME 59 0.0046
527 EAR INFECTION 122 0.0046
528 DRUG PRESCRIBING ERROR 88 0.0046
529 ACUTE RESPIRATORY DISTRESS SYNDROME 81 0.0046
530 MASS 64 0.0046
531 HEPATOMEGALY 45 0.0046
532 PANCREATITIS 242 0.0046
533 COMA 218 0.0046
534 VOMITING 2151 0.0046
535 MUSCLE DISORDER 37 0.0046
536 BONE DISORDER 83 0.0046
537 PULMONARY ARTERIAL HYPERTENSION 66 0.0046
538 VASCULITIS 53 0.0045
539 BLOOD CALCIUM DECREASED 51 0.0045
540 ATRIAL FIBRILLATION 441 0.0045
541 SEPSIS 505 0.0045
542 ORAL HERPES 88 0.0045
543 MUSCULOSKELETAL PAIN 236 0.0045
544 EJECTION FRACTION DECREASED 70 0.0045
545 ANOREXIA 58 0.0045
546 MEDICATION ERROR 250 0.0045
547 NERVE INJURY 50 0.0045
548 DRUG ADMINISTRATION ERROR 138 0.0045
549 FEEDING DISORDER 91 0.0045
550 INTERVERTEBRAL DISC PROTRUSION 98 0.0045
551 FACIAL PAIN 40 0.0045
552 CONFUSIONAL STATE 724 0.0045
553 HAEMATOMA 116 0.0045
554 ANGINA PECTORIS 128 0.0045
555 BLOOD IRON DECREASED 53 0.0045
556 ATAXIA 53 0.0045
557 GASTROENTERITIS 65 0.0044
558 ABASIA 110 0.0044
559 INTENTIONAL DRUG MISUSE 93 0.0044
560 APHASIA 134 0.0044
561 MUSCLE RIGIDITY 53 0.0044
562 POST PROCEDURAL COMPLICATION 85 0.0044
563 DRUG LEVEL DECREASED 45 0.0044
564 MUCOSAL INFLAMMATION 115 0.0044
565 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 229 0.0044
566 SMALL INTESTINAL OBSTRUCTION 54 0.0044
567 EXOSTOSIS 40 0.0044
568 SKIN DISCOLOURATION 201 0.0044
569 DECREASED APPETITE 1014 0.0044
570 SENSORY DISTURBANCE 70 0.0044
571 TEMPERATURE INTOLERANCE 45 0.0044
572 SUICIDE ATTEMPT 262 0.0043
573 EMOTIONAL DISTRESS 523 0.0043
574 BLOOD URINE PRESENT 82 0.0043
575 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 74 0.0043
576 PRODUCT QUALITY ISSUE 586 0.0043
577 VENTRICULAR TACHYCARDIA 71 0.0043
578 DYSPHAGIA 408 0.0043
579 FOOT FRACTURE 81 0.0043
580 PSYCHOTIC DISORDER 126 0.0043
581 WRONG DRUG ADMINISTERED 38 0.0043
582 SWOLLEN TONGUE 133 0.0043
583 THIRST 76 0.0042
584 DYSPEPSIA 418 0.0042
585 HIP ARTHROPLASTY 65 0.0042
586 FALL 1411 0.0042
587 HYPOMAGNESAEMIA 59 0.0042
588 INFECTION 613 0.0042
589 DRUG EFFECT DECREASED 228 0.0042
590 EATING DISORDER 90 0.0042
591 URINARY RETENTION 141 0.0042
592 MADAROSIS 49 0.0042
593 STOMATITIS 256 0.0042
594 PERIPHERAL SWELLING 650 0.0042
595 DYSPNOEA 2388 0.0042
596 LOWER LIMB FRACTURE 81 0.0042
597 GROIN PAIN 37 0.0042
598 BONE DENSITY DECREASED 132 0.0042
599 DYSSTASIA 123 0.0042
600 HAEMOGLOBIN DECREASED 432 0.0042
601 FEELING COLD 117 0.0042
602 PERITONITIS 87 0.0042
603 ACCIDENT 50 0.0042
604 ERYTHEMA 860 0.0042
605 BACTERIAL INFECTION 78 0.0042
606 BURNING SENSATION 293 0.0042
607 INTERNATIONAL NORMALISED RATIO INCREASED 119 0.0042
608 DRUG ADMINISTERED AT INAPPROPRIATE SITE 44 0.0042
609 LIMB INJURY 113 0.0042
610 MIGRAINE 397 0.0042
611 PALPITATIONS 486 0.0041
612 TOOTH LOSS 86 0.0041
613 HEAD INJURY 131 0.0041
614 SKIN ULCER 107 0.0041
615 SKIN LACERATION 45 0.0041
616 MENTAL DISORDER 180 0.0041
617 LOCALISED INFECTION 100 0.0041
618 BLISTER 232 0.0041
619 LOCAL SWELLING 72 0.0041
620 PLEURAL EFFUSION 251 0.0041
621 SKIN LESION 113 0.0041
622 FULL BLOOD COUNT DECREASED 83 0.0041
623 UROSEPSIS 38 0.0041
624 MOVEMENT DISORDER 132 0.0041
625 NEUROTOXICITY 72 0.0041
626 BLOOD GLUCOSE FLUCTUATION 45 0.0041
627 AMNESIA 267 0.0041
628 HAEMATEMESIS 104 0.0041
629 TOOTH INFECTION 54 0.0041
630 FEELING JITTERY 78 0.0041
631 VISION BLURRED 561 0.0041
632 BRONCHITIS 302 0.0041
633 ABDOMINAL PAIN 947 0.0041
634 MUSCULOSKELETAL DISCOMFORT 70 0.0041
635 MOBILITY DECREASED 292 0.0041
636 UNINTENTIONAL MEDICAL DEVICE REMOVAL 47 0.0041
637 INTENTIONAL SELF-INJURY 82 0.0041
638 MYOCARDIAL INFARCTION 708 0.0041
639 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
640 FEELING ABNORMAL 971 0.0040
641 RESPIRATORY DISORDER 121 0.0040
642 UNEVALUABLE EVENT 305 0.0040
643 OESOPHAGITIS 44 0.0040
644 PETECHIAE 42 0.0040
645 EPISTAXIS 300 0.0040
646 WOUND 112 0.0040
647 PERIPHERAL COLDNESS 55 0.0040
648 PAIN IN EXTREMITY 1178 0.0040
649 WHEEZING 237 0.0040
650 DELUSION 62 0.0040
651 PYREXIA 1380 0.0040
652 NIGHTMARE 138 0.0040
653 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
654 ANAEMIA 759 0.0040
655 THINKING ABNORMAL 74 0.0040
656 GAIT DISTURBANCE 760 0.0040
657 PALLOR 108 0.0040
658 PNEUMONIA 1283 0.0040
659 RECTAL HAEMORRHAGE 170 0.0040
660 LIGAMENT SPRAIN 39 0.0039
661 FATIGUE 3070 0.0039
662 CYANOSIS 62 0.0039
663 ASTHENIA 1482 0.0039
664 TINNITUS 181 0.0039
665 SINUS DISORDER 78 0.0039
666 TOOTHACHE 71 0.0039
667 DIZZINESS 1955 0.0039
668 MENTAL IMPAIRMENT 95 0.0039
669 CHILLS 459 0.0039
670 BLOOD GLUCOSE DECREASED 188 0.0039
671 OSTEOPOROSIS 161 0.0039
672 CATARACT 232 0.0039
673 NAUSEA 3078 0.0039
674 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
675 POLLAKIURIA 162 0.0039
676 GINGIVAL BLEEDING 53 0.0039
677 THERAPEUTIC RESPONSE DECREASED 235 0.0039
678 BONE PAIN 226 0.0039
679 CARPAL TUNNEL SYNDROME 54 0.0039
680 ARRHYTHMIA 182 0.0038
681 PARALYSIS 55 0.0038
682 CHOLELITHIASIS 126 0.0038
683 MUSCLE SPASMS 705 0.0038
684 ABDOMINAL DISTENSION 401 0.0038
685 JOINT INJURY 82 0.0038
686 NEUROPATHY PERIPHERAL 364 0.0038
687 PRODUCT AVAILABILITY ISSUE 87 0.0038
688 UPPER LIMB FRACTURE 76 0.0038
689 HYPERCALCAEMIA 47 0.0038
690 WHITE BLOOD CELL COUNT INCREASED 146 0.0038
691 BRAIN OEDEMA 48 0.0038
692 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39 0.0038
693 BALANCE DISORDER 328 0.0038
694 LYMPHADENOPATHY 134 0.0038
695 SCAB 43 0.0038
696 BLINDNESS UNILATERAL 53 0.0038
697 SWELLING 350 0.0037
698 FEELING HOT 229 0.0037
699 HAEMOPTYSIS 104 0.0037
700 PRODUCT PRESCRIBING ISSUE 81 0.0037
701 REBOUND EFFECT 42 0.0037
702 NOCTURIA 45 0.0037
703 GAIT INABILITY 123 0.0037
704 SINUSITIS 377 0.0037
705 ABDOMINAL PAIN UPPER 757 0.0037
706 DIARRHOEA 2365 0.0037
707 MOUTH ULCERATION 77 0.0037
708 SHOCK 84 0.0036
709 ULCER 58 0.0036
710 DIVERTICULITIS 101 0.0036
711 GASTROINTESTINAL PAIN 40 0.0036
712 MUSCLE ATROPHY 46 0.0036
713 DIABETIC KETOACIDOSIS 87 0.0036
714 EUPHORIC MOOD 37 0.0036
715 INTERNAL HAEMORRHAGE 41 0.0036
716 RESPIRATORY TRACT CONGESTION 57 0.0036
717 COUGH 1004 0.0036
718 RED BLOOD CELL COUNT DECREASED 102 0.0036
719 LIVER INJURY 87 0.0035
720 CHROMATURIA 80 0.0035
721 OFF LABEL USE 3086 0.0035
722 HERNIA 68 0.0035
723 COMPLICATION ASSOCIATED WITH DEVICE 51 0.0035
724 BRAIN FOG 55 0.0035
725 RIB FRACTURE 72 0.0035
726 DEVICE LEAKAGE 151 0.0035
727 DEPRESSED MOOD 184 0.0035
728 NIGHT SWEATS 112 0.0035
729 DIPLOPIA 90 0.0035
730 LACTIC ACIDOSIS 112 0.0035
731 ORAL DISCOMFORT 48 0.0035
732 PLATELET COUNT INCREASED 45 0.0034
733 SWELLING FACE 224 0.0034
734 ABDOMINAL DISCOMFORT 577 0.0034
735 BRONCHOSPASM 49 0.0034
736 BLOOD COUNT ABNORMAL 52 0.0034
737 NASAL CONGESTION 201 0.0034
738 CHEST DISCOMFORT 349 0.0034
739 FLUSHING 346 0.0034
740 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
741 SEPTIC SHOCK 147 0.0034
742 BLOOD CREATINE PHOSPHOKINASE INCREASED 97 0.0034
743 ASCITES 99 0.0034
744 LIP SWELLING 112 0.0034
745 PSORIASIS 439 0.0034
746 BLOOD GLUCOSE ABNORMAL 62 0.0034
747 MEMORY IMPAIRMENT 460 0.0033
748 DEVICE ISSUE 300 0.0033
749 WRIST FRACTURE 40 0.0033
750 DRUG DISPENSING ERROR 51 0.0033
751 CARDIAC DISORDER 311 0.0033
752 PRODUCT PHYSICAL ISSUE 67 0.0033
753 DYSPHONIA 194 0.0033
754 PRODUCT ADMINISTRATION ERROR 67 0.0033
755 THYROID DISORDER 51 0.0033
756 PARAESTHESIA 520 0.0033
757 HUNGER 46 0.0033
758 CONDITION AGGRAVATED 997 0.0033
759 EYE INFECTION 37 0.0033
760 HERPES ZOSTER 188 0.0033
761 LUNG DISORDER 160 0.0033
762 THROAT TIGHTNESS 88 0.0033
763 HYPOAESTHESIA ORAL 49 0.0032
764 CHOLECYSTECTOMY 37 0.0032
765 GENERAL PHYSICAL HEALTH DETERIORATION 374 0.0032
766 DEVICE MALFUNCTION 227 0.0032
767 EYE DISORDER 105 0.0032
768 CARDIOVASCULAR DISORDER 81 0.0032
769 DISABILITY 63 0.0032
770 CONJUNCTIVITIS 59 0.0032
771 RASH 1377 0.0032
772 PHARMACEUTICAL PRODUCT COMPLAINT 82 0.0032
773 ALTERED STATE OF CONSCIOUSNESS 68 0.0031
774 CHOKING 61 0.0031
775 GLOSSODYNIA 70 0.0031
776 MYALGIA 531 0.0031
777 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 150 0.0031
778 BEDRIDDEN 41 0.0031
779 MUSCULOSKELETAL STIFFNESS 273 0.0031
780 ABNORMAL DREAMS 86 0.0031
781 SINUS CONGESTION 42 0.0031
782 LIMB DISCOMFORT 96 0.0031
783 DERMATITIS 65 0.0031
784 BLOOD GLUCOSE INCREASED 583 0.0031
785 INJECTION SITE INDURATION 40 0.0031
786 DRUG INEFFECTIVE 4054 0.0031
787 INFLUENZA 343 0.0031
788 CLOSTRIDIUM DIFFICILE INFECTION 67 0.0031
789 OROPHARYNGEAL PAIN 284 0.0031
790 PRODUCT PREPARATION ERROR 63 0.0031
791 CARDIAC FAILURE 245 0.0030
792 GLYCOSYLATED HAEMOGLOBIN INCREASED 77 0.0030
793 KNEE ARTHROPLASTY 64 0.0030
794 MALAISE 1332 0.0030
795 PHOTOSENSITIVITY REACTION 50 0.0030
796 HOT FLUSH 228 0.0030
797 INTESTINAL OBSTRUCTION 114 0.0030
798 RHINORRHOEA 195 0.0030
799 DEEP VEIN THROMBOSIS 196 0.0030
800 DRUG DOSE OMISSION 495 0.0030
801 DEVICE USE ERROR 104 0.0030
802 CEREBRAL HAEMORRHAGE 107 0.0030
803 HIP FRACTURE 96 0.0030
804 VISUAL ACUITY REDUCED 99 0.0030
805 NERVOUS SYSTEM DISORDER 93 0.0030
806 PHOTOPHOBIA 56 0.0030
807 THROMBOSIS 239 0.0030
808 FLATULENCE 168 0.0030
809 HAEMATOCHEZIA 163 0.0030
810 SPINAL FRACTURE 59 0.0029
811 SUBDURAL HAEMATOMA 42 0.0029
812 MULTIPLE FRACTURES 48 0.0029
813 THERAPEUTIC RESPONSE UNEXPECTED 131 0.0029
814 ANAPHYLACTIC REACTION 161 0.0029
815 DRUG WITHDRAWAL SYNDROME NEONATAL 43 0.0029
816 NEPHROLITHIASIS 133 0.0029
817 LEUKOPENIA 145 0.0029
818 DYSGEUSIA 215 0.0029
819 DRUG DEPENDENCE 465 0.0029
820 ARTHRALGIA 1202 0.0029
821 INFLAMMATION 149 0.0029
822 LYMPHOCYTE COUNT DECREASED 51 0.0029
823 INCORRECT DRUG ADMINISTRATION DURATION 81 0.0029
824 UNDERDOSE 210 0.0029
825 DEVICE ADHESION ISSUE 44 0.0029
826 PRURITUS GENERALISED 62 0.0029
827 ILLNESS 295 0.0029
828 GLAUCOMA 55 0.0029
829 LABORATORY TEST ABNORMAL 84 0.0028
830 PNEUMOTHORAX 45 0.0028
831 THROAT IRRITATION 127 0.0028
832 HEPATIC CIRRHOSIS 53 0.0028
833 RASH GENERALISED 73 0.0028
834 HYPOCALCAEMIA 53 0.0028
835 BLINDNESS 114 0.0028
836 DEMENTIA 78 0.0028
837 MULTIPLE ORGAN DYSFUNCTION SYNDROME 79 0.0028
838 TOOTH DISORDER 62 0.0028
839 INTENTIONAL PRODUCT USE ISSUE 244 0.0028
840 VERTIGO 169 0.0028
841 ASPARTATE AMINOTRANSFERASE INCREASED 147 0.0028
842 PRESCRIBED UNDERDOSE 55 0.0028
843 INSURANCE ISSUE 42 0.0027
844 ISCHAEMIC STROKE 49 0.0027
845 ANGIOEDEMA 121 0.0027
846 FAECES DISCOLOURED 59 0.0027
847 PLATELET COUNT DECREASED 289 0.0027
848 PARAESTHESIA ORAL 39 0.0027
849 SNEEZING 60 0.0027
850 PRODUCT USE COMPLAINT 42 0.0027
851 EYE SWELLING 99 0.0027
852 ADVERSE DRUG REACTION 239 0.0027
853 PRURITUS 1021 0.0027
854 GASTRIC DISORDER 91 0.0026
855 URTICARIA 444 0.0026
856 DRUG EFFECT INCOMPLETE 96 0.0026
857 ALOPECIA 518 0.0026
858 ARTHRITIS 207 0.0026
859 GASTRIC ULCER 50 0.0026
860 DISCOMFORT 160 0.0026
861 INTENTIONAL DOSE OMISSION 74 0.0026
862 PRODUCT USE IN UNAPPROVED INDICATION 634 0.0026
863 NASOPHARYNGITIS 469 0.0025
864 RASH PAPULAR 57 0.0025
865 INJECTION SITE MASS 94 0.0025
866 HEAD DISCOMFORT 45 0.0025
867 THERAPY CESSATION 130 0.0025
868 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 43 0.0025
869 COGNITIVE DISORDER 118 0.0025
870 LIVER FUNCTION TEST INCREASED 54 0.0025
871 ABSCESS 40 0.0025
872 VISUAL IMPAIRMENT 310 0.0025
873 BASAL CELL CARCINOMA 39 0.0025
874 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 506 0.0025
875 PULMONARY EMBOLISM 237 0.0025
876 PRODUCTIVE COUGH 119 0.0025
877 HYPOACUSIS 107 0.0025
878 PRODUCT DOSE OMISSION 161 0.0025
879 FUNGAL INFECTION 82 0.0025
880 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 175 0.0025
881 ALANINE AMINOTRANSFERASE INCREASED 151 0.0025
882 GASTROINTESTINAL DISORDER 219 0.0024
883 INFLUENZA LIKE ILLNESS 200 0.0024
884 COLITIS 92 0.0024
885 PANCYTOPENIA 135 0.0024
886 RASH MACULAR 84 0.0024
887 HEPATIC FAILURE 72 0.0024
888 RESPIRATORY TRACT INFECTION 62 0.0024
889 ERUCTATION 46 0.0024
890 HAEMORRHAGE 248 0.0024
891 TASTE DISORDER 48 0.0024
892 MUSCULOSKELETAL DISORDER 45 0.0024
893 RASH PRURITIC 128 0.0024
894 EYE PAIN 133 0.0024
895 LIVER FUNCTION TEST ABNORMAL 68 0.0023
896 LACRIMATION INCREASED 70 0.0023
897 LOWER RESPIRATORY TRACT INFECTION 105 0.0023
898 PROCEDURAL PAIN 64 0.0023
899 BLOOD BILIRUBIN INCREASED 62 0.0023
900 ARTHROPATHY 126 0.0023
901 DRY EYE 113 0.0023
902 ERECTILE DYSFUNCTION 58 0.0023
903 HOSPITALISATION 347 0.0023
904 PELVIC PAIN 41 0.0023
905 ADVERSE EVENT 206 0.0022
906 SURGERY 131 0.0022
907 PREMATURE BABY 67 0.0022
908 AMENORRHOEA 39 0.0022
909 DEAFNESS 58 0.0022
910 CEREBRAL INFARCTION 54 0.0022
911 ILL-DEFINED DISORDER 133 0.0022
912 FREQUENT BOWEL MOVEMENTS 59 0.0022
913 SKIN CANCER 47 0.0022
914 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 155 0.0022
915 C-REACTIVE PROTEIN INCREASED 79 0.0022
916 FEBRILE NEUTROPENIA 144 0.0022
917 AGEUSIA 54 0.0022
918 PRODUCT DOSE OMISSION ISSUE 634 0.0022
919 EOSINOPHILIA 37 0.0021
920 ABDOMINAL PAIN LOWER 53 0.0021
921 INJECTION SITE REACTION 144 0.0021
922 PAIN OF SKIN 56 0.0021
923 EXPIRED PRODUCT ADMINISTERED 69 0.0021
924 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 48 0.0021
925 CHOLESTASIS 39 0.0020
926 SYSTEMIC LUPUS ERYTHEMATOSUS 72 0.0020
927 WHITE BLOOD CELL COUNT DECREASED 215 0.0020
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 353 0.0020
929 JAUNDICE 52 0.0019
930 SKIN EXFOLIATION 163 0.0019
931 THERAPY INTERRUPTED 137 0.0019
932 DRUG-INDUCED LIVER INJURY 60 0.0019
933 HEPATOTOXICITY 42 0.0019
934 THERAPEUTIC PRODUCT EFFECT DECREASED 84 0.0019
935 ANAPHYLACTIC SHOCK 48 0.0019
936 SKIN IRRITATION 85 0.0019
937 LIVER DISORDER 82 0.0018
938 DEVICE BREAKAGE 75 0.0018
939 PRODUCT DISPENSING ERROR 40 0.0018
940 DEATH 1574 0.0018
941 NEEDLE ISSUE 53 0.0018
942 MATERNAL EXPOSURE DURING PREGNANCY 159 0.0018
943 PNEUMONITIS 48 0.0018
944 INCORRECT DOSE ADMINISTERED 402 0.0018
945 FOETAL EXPOSURE DURING PREGNANCY 143 0.0018
946 EYE IRRITATION 100 0.0017
947 FEMUR FRACTURE 53 0.0017
948 COVID-19 298 0.0017
949 THERAPEUTIC RESPONSE SHORTENED 54 0.0016
950 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
951 VAGINAL HAEMORRHAGE 70 0.0016
952 HEPATITIS 41 0.0016
953 OCULAR HYPERAEMIA 76 0.0016
954 SKIN BURNING SENSATION 114 0.0016
955 LUNG NEOPLASM MALIGNANT 65 0.0016
956 DISEASE PROGRESSION 187 0.0016
957 EYE PRURITUS 52 0.0015
958 EPILEPSY 47 0.0015
959 DRUG RESISTANCE 39 0.0015
960 DISEASE RECURRENCE 72 0.0015
961 INCORRECT ROUTE OF DRUG ADMINISTRATION 54 0.0015
962 NEUTROPENIA 203 0.0015
963 DRY SKIN 199 0.0015
964 EXTRA DOSE ADMINISTERED 60 0.0015
965 DEVICE DIFFICULT TO USE 98 0.0015
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 69 0.0015
967 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
968 NEUTROPHIL COUNT DECREASED 59 0.0014
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 48 0.0014
970 NO ADVERSE EVENT 256 0.0014
971 MULTIPLE SCLEROSIS 66 0.0014
972 PSORIATIC ARTHROPATHY 56 0.0014
973 INJECTION SITE BRUISING 109 0.0014
974 INJECTION SITE PAIN 414 0.0013
975 PLASMA CELL MYELOMA 52 0.0013
976 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37 0.0013
977 NEOPLASM MALIGNANT 81 0.0012
978 INJECTION SITE PRURITUS 81 0.0012
979 INJECTION SITE HAEMORRHAGE 96 0.0012
980 ECZEMA 61 0.0012
981 MALIGNANT NEOPLASM PROGRESSION 112 0.0011
982 NEOPLASM PROGRESSION 38 0.0011
983 INJECTION SITE ERYTHEMA 134 0.0011
984 INJECTION SITE SWELLING 80 0.0010
985 DERMATITIS ATOPIC 53 0.0010
986 MULTIPLE SCLEROSIS RELAPSE 68 0.0010
987 ACNE 73 0.0010
988 BREAST CANCER 89 0.0010
989 COLITIS ULCERATIVE 42 0.0009
990 ACCIDENTAL EXPOSURE TO PRODUCT 96 0.0009
991 INTERSTITIAL LUNG DISEASE 41 0.0008
992 DRUG DOSE OMISSION BY DEVICE 63 0.0008
993 PRODUCT STORAGE ERROR 54 0.0006